The neuroscience behind the shift
Modern neuroscience suggests ketamine promotes rapid neuroplasticity, helping the brain form new connections after long periods of stress or emotional rigidity. This may allow well-worn pathways of fear and rumination to loosen, creating a window in which new emotional and cognitive patterns can begin to take shape.
The brain’s default mode network is closely linked to self-referential thinking—the inner narrator that often dominates during anxiety and depression. Research shows ketamine can temporarily modulate this network, allowing people to experience thoughts with less attachment. Clinically, this is often felt as a “reset”: not erasing one’s identity, but loosening its grip.
Many people spend years in therapy—gaining genuine insight, understanding their patterns—and still feel stuck. This is not a failure of effort. Talk therapy works largely top-down: it engages the thinking mind to reason about experience. But trauma and chronic stress are held deeper—in the body’s automatic responses to threat.
When the nervous system has learned to expect danger, it can remain stuck in patterns of hyper-alertness (anxiety, tension, irritability) or shutdown (numbness, fatigue, disconnection), even when life is objectively safe. Cognitive understanding alone rarely reaches this level. Insight, no matter how accurate, does not automatically regulate the nervous system.
“I understand why I feel this way… but nothing seems to change.”
Medications can blunt symptoms, but they don’t necessarily resolve the underlying disconnection—and over-reliance can quietly reinforce avoidance rather than integration.
Ketamine works bottom-up, temporarily loosening rigid patterns in the brain and nervous system:
During this brief window of flexibility, people often find it easier to approach difficult material with curiosity and compassion rather than overwhelm—a felt sense of perspective, relief, or connection that cognitive approaches alone rarely produce. This is not just subjective—it reflects temporary changes in brain network activity.
Not a cure-all. Not symptom suppression. Not escape. Ketamine is best understood as a catalyst — it creates the conditions in which real healing becomes possible.
Ketamine has been used safely in medical settings for over 50 years and is recognized by the World Health Organization as an essential medication for anesthesia and pain management. Over the past two decades, it has also been extensively studied for its effects on mood and stress regulation. Important discoveries have been made describing its effects on brain development and neuroplasticity.
In therapeutic practice, ketamine is administered via intravenous (IV), intramuscular (IM), nasal and oral routes, each with its pros and cons. Esketamine, an isomer of Ketamine, is FDA-approved for treatment-resistant depression which is defined by individuals whose depression has failed to respond to multiple treatment modalities. This nasal route is slowly absorbed and results in a lighter effect than IM or IV ketamine. IV and IM ketamine have a much more rapid onset resulting in a higher degree of dissociative effects, or what is commonly referred to as “ego dissolution.” Although this use is considered off-label—meaning it is not FDA-approved for these specific indications—it is supported by clinical research and accepted medical practice when prescribed and administered by a licensed clinician. Deciding on the best approach for your ketamine treatment will be a collaborative decision made after an appropriate intake evaluation.
Nikolin, S., Rodgers, A., Schwaab, A., Bahji, A., Zarate, C. A., Vazquez, G., & Loo, C. (2023). Ketamine for the treatment of major depression: A systematic review and meta-analysis. eClinicalMedicine, 62.
This systematic review and meta-analysis evaluated randomized controlled trials examining ketamine formulations for major depressive disorder. The analysis, which included 49 studies involving 3,299 participants, showed an association in reductions in depressive symptom severity compared with control conditions.
Ketamine research continues to evolve. Large-scale, long-term studies are ongoing, particularly regarding optimal dosing, durability of effects, and predictors of response. This evolving evidence underscores the importance of medical supervision, psychological support, and informed consent.
Ketamine-assisted therapy can help guide you toward profound healing and personal growth. Dr. Almeida provides safe and supportive preparation, medicine and integration and encourages supportive therapy and comprehensive support for those seeking deeper therapeutic interventions. The value of a holistic perspective that addresses both symptoms and root causes of mental health concerns cannot be overstated. Continuity and ongoing work with a therapist and/or psychiatrist is strongly recommended. For patients with more complex psychiatric histories, it may be required as a condition of treatment.